{"product_id":"biolegend-400114","title":"Biolegend, 400114, PE Mouse IgG1, κ Isotype Ctrl (FC) Antibody, 100tests","description":"\u003cp\u003eThe MOPC-21 immunoglobulin has unknown specificity. The isotype of this antibody is mouse IgG1, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.\u003cbr\u003e\n100tests\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Mouse\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)\u003cbr\u003e\nPreparation: The immunoglobulin was purified by affinity chromatography, and conjugated with PE under optimal conditions.\u003cbr\u003e\nConcentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)\u003cbr\u003e\nStorage \u0026amp; Handling: The IgG1, κ isotype control solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this mouse IgG1, κ isotype control antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, use the isotype control at the same concentration as your primary antibody. Use our Concentration Lookup tool to find the exact concentrations of your lots of product.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)Green Laser (532 nm)\/Yellow-Green Laser (561 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: Intracellular Flow Cytometry (ICFC), Immunocytochemistry (ICC), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), Functional Assay (FA)\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Carlsten M, et al. 2007. Cancer Res. 67:1317. PubMed Smed-Sörensen A, et al. 2008. Blood 111:5037. PubMed (FA) Bunesmann MM, et al. 2011. Am. J. Respir. Cell. Mol. Biol. Epub. PubMed Matsuyama T, et al. 2005. Infect. Immun. 73:1044. (IF) Correia DV, et al. 2011. Blood 118:992. (FC) PubMed Lian IA, et al. 2011. Placenta. 32:823. PubMed Bufe B, et al. 20015. J Biol Chem. 290:7369. PubMed\u003cbr\u003e\nProduct Citations: Chalubinski M, et al. 2015. Vascul Pharmacol. . PubMed Sreevalsan S, et al. 2020. EMBO Rep. 21:e50155. PubMed Fan Y, et al. 2021. Stem Cell Res Ther. 207:12. PubMed Kaspi E, et al. 2017. PLoS One.. 10.1371\/journal.pone.0183136. PubMed Pelon F, et al. 2020. Nat Commun. 0.738888889. PubMed Redka DS, et al. 2018. Mol Biol Cell. 29:53. PubMed Jenkins E, et al. 2023. Nat Commun. 14:1611. PubMed Reichenbach P, et al. 2023. Nat Biomed Eng. . PubMed Imai H, et al. 2023. iScience. 26:106822. PubMed Sonoda S, et al. 2022. STAR Protoc. 3:101386. PubMed Kashima Y, et al. 2021. Cancer Res. 81:4835. PubMed Oh S, et al. 2022. Pediatr Int. :e15390. PubMed Martínez-Sabadell A, et al. 2022. Cell Rep. 41:111430. PubMed Hasegawa K, et al. 2022. Cells. 11: . PubMed Ding L, et al. 2023. J Clin Invest. 133: . PubMed Krammer S, et al. 2022. Cells. 12: . PubMed Wang CQ, et al. 2023. Cells. 12: . PubMed Tuohinto K, et al. 2023. PLoS Pathog. 19:e1010753. PubMed Lee JY, et al. 2023. Cancer Immunol Immunother. :. PubMed Tse A, et al. 2013. J Biol Chem. 288:29923. PubMed Han L, et al. 2012. PLoS One. 4:e7989. PubMed Ryzhov S, et al. 2019. J Am Heart Assoc. 8:e010874. PubMed Liu R, et al. 2022. Aging Dis. 13:1576. PubMed Stepanenko AA, et al. 2021. Sci Rep. 11:16088. PubMed Kazemi S, et al. 2020. Biochem Pharmacol. 114317:183. PubMed Liu MY, et al. 2019. Oncol Lett. 18:3664. PubMed Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed Fernandez MV, et al. 2020. J Virol. :94. PubMed Crespo ÂC, et al. 2020. Cell. 182(5):1125-1139. PubMed Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed Alysandratos KD, et al. 2021. Cell Reports. 36(9):109636. PubMed Ruetsche D, et al. 2022. Cells. 11:. PubMed Kobayashi Y, et al. 2020. Int J Oncol. 999:56. PubMed Stein N, et al. 2019. iScience. 0.781944444. PubMed Ali S, et al. 2018. Purinergic Signal. 14:371. PubMed Murata K, et al. 2019. Oncol Lett. 17:5830. PubMed Pein M, et al. 2020. Nat Commun. 11:1494. PubMed Zhu Z, et al. 2020. Cell Stem Cell. 26(2):187-204.e10.. PubMed Hatano R, et al. 2015. J Immunol. 194:960. PubMed Menck K, et al. 2015. J Mol Cell Biol. 7:143. PubMed Eriksson E, et al. 2019. J Immunol. 202:787. PubMed Nathan AA, et al. 2017. Trop Med Int Health. 22:1414. PubMed Li B, et al. 2019. Stem Cell Res Ther. 10:257. PubMed Costa A et al. 2018. Cancer cell. 33(3):463-479 . PubMed Coelho PP, et al. 2022. Nat Commun. 13:3812. PubMed Sapey E, et al. 2014. Blood. 123:239. PubMed Chandran P, et al. 2014. J Leukoc Biol. 96:633. PubMed Stocco E, et al. 2020. Front Cell Dev Biol. 0.515972222. PubMed Stepanenko AA, et al. 2022. Mol Ther Oncolytics. 24:230. PubMed Yan K, et al. 2022. iScience. 25:104822. PubMed Zadeh VR, et al. 2020. J Gen Virol. 101:573. PubMed Ann Butler C, et al. 2021. Journal of Neurochemistry. . PubMed Wu L, et al. 2018. Oncol Lett. 15:9507. PubMed Wang X, et al. 2021. Front Endocrinol (Lausanne). 12:666195. PubMed Kotetsu Y, et al. 2021. Biomedicines. 9:. PubMed McCauley KB, et al. 2018. Curr Protoc Stem Cell Biol. 45:e51. PubMed Saga R, et al. 2019. Oncol Lett. 17:3555. PubMed Chiang N et al. 2018. Cell chemical biology. 26(2):244-254 . PubMed Saga R, et al. 2019. J Radiat Res. 60:298. PubMed Chalubinski M, et al. 2021. APMIS. 129:143. PubMed Okita R, et al. 2021. Thorac Cancer. 12:775. PubMed Sharma N,et al. 2017. J Immunol. 10.4049\/jimmunol.1700647. PubMed Klymenko T, et al. 2018. Leukemia. 19:E499. PubMed Iwasa M, et al. 2019. Oncotarget. 10:1903. PubMed Qin XH, et al. 2019. Langmuir. 35:1882. PubMed Yoshida R, et al. 2022. Cancer Res. :. PubMed Suzuki S, et al. 2021. STAR Protocols. 2:100683. PubMed Mikulkova Z, et al. 2021. Sci Rep. 11:322. PubMed Panagioti E, et al. 2021. J Clin Invest. 131:. PubMed Heskamp S, et al. 2015. Cancer Res . 75: 2928 - 2936. PubMed Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed Navarro-Guerrero E, et al. 2021. Sci Rep. 11:4245. PubMed Arenas EJ, et al. 2021. Nat Commun. 12:1237. PubMed Kim WK, et al. 2015. AIDS Res Hum Retroviruses . 31: 696-706. PubMed Hawkins FJ, et al. 2020. Cell Stem Cell. 28(1):79-95.e8. PubMed Ye Z, et al. 2018. Cancer Med. 2.414583333. PubMed Matsuyama H, et al. 2019. Sci Rep. 9:13181. PubMed Lu Y, et al. 2020. STAR Protoc. 1:100040. PubMed Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed Ayala-Grosso C, et al. 2020. Biomedica. 40:72. PubMed Herbrich SM, et al. 2018. Oncotarget. 9:30092. PubMed Guo Y, et al. 2021. Nat Commun. 12:2623. PubMed Chen C, et al. 2022. iScience. 25:103645. PubMed Hwang HJ, et al. 2021. Immun Inflamm Dis. 9:274. PubMed Hu W, et al. 2022. Mater Today Bio. 14:100224. PubMed Park S, et al. 2021. Int J Stem Cells. 14:400. PubMed\u003cbr\u003e\nRRID: AB_326435 (BioLegend Cat. No. 400113) AB_326435 (BioLegend Cat. No. 400114)\u003cbr\u003e\nGene ID: NA\u003cbr\u003e\nClone: MOPC-21\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nIsotype: Mouse IgG1, κ\u003cbr\u003e\nQ: What type of PE do you use in your conjugates?\u003cbr\u003e\nA: We use R-PE in our conjugates.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46866142036137,"sku":"400114","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/es\/products\/biolegend-400114","provider":"Iright","version":"1.0","type":"link"}